Synaffix B.V.

Synaffix B.V. is a biotechnology company that develops ADC product candidates using its clinical-stage, site-specific ADC technology platform.

A series of dice with a bag on them illustrating cost cuts
Biotech

Elevation drops sole clinical-stage ADC, lays off 70% of staff

Elevation is ditching its sole clinical-stage asset in the wake of disappointing phase 1 data, leading the ADC company to lay off 70% of its staff.
James Waldron Mar 20, 2025 10:20am
graphic image of different colored hands shaking

Sotio takes up option on ADCs, Boehringer inks discovery pact

Mar 13, 2025 10:53am
visual rendering of an antibody drug conjugate

Lonza's Synaffix inks ADC technology pact with Boehringer

Jan 9, 2025 8:00am
Photo of a final puzzle piece about to fit into a puzzle

Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal

Dec 12, 2024 9:19am
lots of hats

BigHat, Synaffix collab outfits AI science with ADC tech

Nov 4, 2024 11:07am
Photo of two hands shaking

After halting lead asset, Sotio signs $740M deal with Synaffix

Oct 16, 2023 3:00am